PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases of Hospital Geral De Roraima. Universidade Federal De Roraima. Boa Vista Brazil.\', \'Post Graduate Program in Health Science of Universidade Federal De Roraima, Health Science Center, Boa Vista, Brazil.\', \'Clinical Research Center of the Oncological Center of Roraima - Boa Vista - Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/20477724.2021.1890887
?:doi
?:hasPublicationType
?:journal
  • Pathogens and global health
is ?:pmid of
?:pmid
?:pmid
  • 33682640
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.844
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all